U.S. biotechnology company Avril Biopharma said on Monday it has acquired the assets of United States Pharmacopeia (USP) Ghana and established AfriVax GH Ltd to expand its contract development and manufacturing (CDMO) business in Africa. The company offers development services using hen eggs to produce valuable clinical, veterinary and food-security products. The acquisition comes as African leaders push for greater vaccine self-sufficiency in the wake of the COVID-19 pandemic and reductions in international support for capacity building in the African healthcare space.
Read the full article: Avril Biopharma Acquires USP-Ghana Assets //
Source: https://www.einpresswire.com/article/831623875/avril-biopharma-acquires-usp-ghana-assets-launches-african-vaccine-manufacturing-technology-push